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Owing to the cross-sectional design of the study, the evolution in space and time of the BBB alterations could not be assessed in individual subjects. Although Montagne et al. focused on cognitively normal or mildly affected subjects, it would be of instructive to examine the spatiotemporal evolution of the BBB alterations in MCI patients who go on to develop frank AD. Recent data indicate that AD pathology and the associated synaptic dysfunction spread throughout the brain according to a stereotyped pattern, largely reflecting neuronal connectivity (Spires-Jones and Hyman, 2014) . It would be informative to determine if the BBB alteration follows a similar progression and, if so, whether it precedes or follows the spread of amyloid and tau.
Another question concerns the role of BBB disruption in white matter pathology. Subcortical white matter lesions, assumed to be on ischemic bases, are common in older subjects and are an important correlate of cognitive decline in aging, MCI, and AD (Iadecola, 2013) . Although less pronounced than in the hippocampus, Montagne et al. observed a trend for increased permeability in the white matter, especially in MCI, raising the possibility that BBB leakage and not ischemia is an early determinant of white matter damage. Using their highresolution imaging method, it would be feasible for the first time to determine if BBB leakage precedes white matter damage, which is still unsettled in the literature (Iadecola, 2013 disrupts information transfer through the cortico-basal ganglia circuit and impairs normal selection or suppression of actions (Brown, 2007) . PD is characterized by the loss of dopamine in the basal ganglia (BG) circuit that leads to devastating motor dysfunction. Symptom progression has been linked to the appearance of highly synchronized oscillatory activity across cortico-basal ganglia regions, particularly in the beta frequency range (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) where the origin and mechanism of action is unknown (Brown 2007) . Moreover, the current treatments-dopamine replacement and high-frequency deep brain stimulationtarget BG nuclei and often disrupt or resolve abnormal beta oscillations, but pathological activity patterns quickly return if treatments are interrupted.
The reciprocally connected subthalamic nucleus (STN) and external segment of the globus pallidus (GPe) form a central pacemaker in the BG that has been implicated in the onset, progression, and maintenance of harmful oscillatory activity (Bevan et al., 2002) . In healthy individuals, STNGPe activity is desynchronized and uncorrelated, and its relationship to voluntary movement is characterized by complex spatiotemporal firing (Wichmann and DeLong, 1996) . The STN receives monosynaptic cortical excitation, known as the hyperdirect pathway, which has been linked to a rapid, immediate stop signal (Schmidt et al., 2013) . The STN also receives indirect cortical information through the GPe, known as the indirect pathway, which is responsible for the suppression or cancellation of motor plans (Sano et al., 2013) .
Neurons in the STN must integrate the GABAergic input from the GPe and the glutamatergic input from the cortex to appropriately stop or pause behaviors. Therefore, the balance between cortical excitation and pallidal inhibition are critical for normal function, and perturbations may underlie disease conditions.
In idiopathic and experimental PD, the activity of STN-GPe network becomes highly synchronized and rhythmic with the emergence of beta-band frequency activity (Bevan et al., 2002) . The synaptic mechanisms driving this change in patterning are unknown, but the STNGPe network is well positioned to produce and propagate harmful oscillations. Computational modeling paired with experimental observations have shown that extensive GPe collaterals, strong but selective reciprocity of the STN-GPe connections, and intrinsic autonomous properties provide the necessary tools to create a strong oscillator (Holgado et al., 2010; Plenz and Kital, 1999) . In this issue of Neuron, Chu et al. discover that high levels of cortical activity onto STN neurons can induce heterosynaptic longterm potentiation (hLTP) of GPe synapses. Strengthening of GPe inputs to the STN after dopamine depletion has been shown previously (Fan et al., 2012) , but the important conceptual advance of the present study is that the potentiation of GPe synapses is mechanistically linked to that of cortical synapses. The authors hypothesize that under normal conditions, hLTP serves an adaptive, homeostatic role to maintain a healthy balance between the hyperdirect and indirect pathway in the STN. However, after dopamine depletion, pathologically elevated cortical input to the STN triggers excessive induction of hLTP at GPe synapses, which becomes maladaptive to circuit function and contributes to or even exacerbates pathological oscillations.
Several mechanisms of heterosynaptic plasticity have been described at GABAergic synapses (Castillo et al., 2011) . One mechanism in particular, NMDA-dependent release of nitric oxide (NO) to strengthen nearby inhibitory synapses (Nugent et al., 2007) (M1) with a channelrhodopsin-containing virus and optically stimulated terminals in the STN. GPe inputs were activated using electrical stimulation through an electrode placed within the internal capsule. Using multiple pharmacological manipulations, the authors demonstrate that presynaptic, NO-dependent plasticity is present at GPe-STN synapses. However, upon further experimentation, the authors found that a presynaptic mechanism was not the only mechanism of hLTP at the synapse. In the presence of a NOS inhibitor, postsynaptic hLTP was rescued by directly activating NMDA receptors. Two approaches were used to uncover the postsynaptic mechanism contributing to hLTP. First, immunohistochemistry revealed an increase in the density of the GABA A R scaffolding protein, gephyrin, as well as an increase in the density of the g2 subunit of the GABA A R after hLTP induction, consistent with the findings of Fan et al. (2012) , in dopamine-depleted tissue. Second, uncaging of RuBi-GABA produced larger inhibitory responses after hLTP induction compared to baseline, consistent with the increase in the number of GABA A R observed immunohistochemically. These results show for the first time that hLTP has both a presynaptic (NO-GC-PKG signal cascade) and postsynaptic (SNARE-dependent insertion of GABA A Rs) mechanism at the same synapse (Figure 1) . To determine whether hLTP is present in vivo, the authors used a viral strategy to knock down expression of the GluN1 subunit, and hence NMDARs, in a portion of STN neurons; if hLTP is normally engaged in vivo, the strength of inhibitory inputs should be decreased onto neurons lacking NMDARs. Comparisons of the frequency and amplitude of miniature inhibitory postsynaptic currents (mIPSCs) recorded from infected and uninfected neurons showed that inhibitory inputs were indeed weakened onto neurons lacking NMDARs in both control and dopamine-depleted slices. These results confirmed that NMDAR activity can modulate the strength of GPe-STN inputs under both control and dopaminedepleted conditions.
If the strengthening of GPe-STN synapses via hLTP acts in a homeostatic manner, then it should help to preserve a constant ratio between excitation and inhibition. This prediction was tested under control conditions, where the authors measured the ratio of excitatory and inhibitory synaptic inputs both pre-and post-induction of hLTP. In support of a homeostatic function, the ratio of excitation and inhibition remained constant. The fact that hLTP is regulated by the degree of activity of cortical inputs to the STN suggests that the excessive cortical patterning that occurs after dopamine loss could drive hLTP at GPe-STN synapses to maximal capacity. To test this idea, the authors attempted to induce hLTP in acute slices prepared from dopaminedepleted mice, but found that it was occluded. This occlusion experiment implies that hLTP is maximally engaged at all GPe-STN synapses after dopamine depletion. However, the results of the viral knockdown experiment showed that hLTP was also present at some synapses under control conditions, so there may be other factors contributing to hLTP occlusion after dopamine depletion. One possibility is that hLTP ceases to be homeostatic under dopamine-depleted conditions, but the ratio between excitatory and inhibitory inputs was not examined in dopamine-depleted mice, so this remains an open question.
How might hLTP contribute to pathological oscillations in the Parkinsonian brain? We know from in vivo studies of PD patients and animal models that cortical excitation becomes more synchronous and out of phase to pallidal inhibition (Goldberg et al., 2002; Mallet et al., 2008) . This may be the force necessary to activate NMDA-dependent plasticity and drive the strengthening of GPe-STN synapses. This increase in GPe synaptic strength could then further promote pathological activity by deinactivation of Na v channels (Baufreton et al., 2005) . Therefore, inducing hLTP in the STN-GPe network that contains an intrinsic propensity for oscillations (STN excites GPe, GPe inhibits STN) would not only be able to mimic the beta-band oscillations but also propagate them to multiple brain regions.
Interestingly, a patient with PD must experience profound dopamine loss before the onset of motor dysfunction. The hLTP mechanism presented here fits well into how this may occur. An individual will experience a gradual loss of dopamine, which results in changes in firing rate and pattern of GPe and cortical inputs and therefore engages hLTP. The STN may be able to balance the changing landscape of basal ganglia firing and pattern for a period of time but eventually is unable to overcome the loss of an important neuromodulator and other anatomical and physiological changes in connected brain regions. There then comes a point where the synaptic mechanism switches from adaptive to maladaptive. Dopamine replacement therapy can restore some functionality to the circuit, but if synaptic mechanisms such as hLTP are not reversed, circuit dysfunction will persist until solutions are found to restore synaptic connections to healthy states.
